BioAtla Inc Sustainability Reports
BioAtla is a clinical-stage biotechnology company developing conditional active biological antibody therapeutics for the treatment of solid tumor cancers.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
5 reports from 2020 to 2024
Company Profile
BioAtla is a clinical-stage biotechnology company developing conditional active biological antibody therapeutics for the treatment of solid tumor cancers.
Reports
5 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
